Clinical Trial Update: THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring

View source ↗

Summary

The GIRAFFE study reports on genomic risk markers for atrial fibrillation in patients with symptoms of cardiac arrhythmia after extended rhythm monitoring; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Scripps Translational Science Institute | Conditions: Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation | Status: COMPLETED